Introduction
Hematology analyzers are specific and electronic systems that count leucocytes, platelets and red cells in the blood, and furthermore decides the level of hemoglobin and hematocrit in blood. This analyzer is the part of medical sciences mainly related to the research, diagnosis, and treatment of blood-related disorders. It had increased pace in a generally brief span of time. In the conventional system, the process of complete blood count (CBC) was performed physically by a specialist before a magnifying instrument.
Market Overview
The Global Hematology Analyzer Market was valued at $ XX Mn in 2018 and is forecast to grow at a strong XX% CAGR between 2018 and 2026, resulting in 2026 global sales of $ XX. Market-driven by rising demand for it-driven medical information networks and the combination of basic flow-cytometry techniques in automated hematology analyzers is some of the components driving the market. However, threats of newcomers and stiff competition among existing players are the components hindering the market. Moreover, increasing occurrences of business among hematology instruments providers and manufacturers will offer lucrative open opportunities in the market.
Hematology Analyzer Market depending on Type, Automatic Hematology Analyzers are driving due to the ability to make and stain slides. This is intended to meet the needs of high-volume laboratories. It can gauge a few diagnostic parameters, for example, White Blood Cell (WBC) or leukocyte count, lymphocyte percent and number, mononuclear cell percent and number, granulocyte percent and number, Red Blood Cell (RBC). High-throughput labs require automation of their hematology work process and the ability to coordinate with different frameworks. Factors to consider are throughput, autoloader capacity, and whether vials and racks are compatible with other lab equipment.
Key Developments
Segmentation
The Global Hematology Analyzer Market is segmented on the basis of type, Product, number of Parameters, End-user and Geography.
Based on the Type: Semiautomatic Hematology Analyzers and Automatic Hematology Analyzers
Based on the Product: Instruments and Consumables.
Based on the Number of Parameters: Up to 10 Parameters, 10-30 Parameters and Above 30 Parameters.
Based on the End User: Laboratory, Hospital, Research Institutes, and Commercial organizations
Based on Region: North America, Asia-Pacific, Europe, and LAMEA. Among that Asia Pacific region is projected to witness due to the rising focus toward emerging markets, such as India and China, could also open up opportunities for new players in the global hematology analyzer. Moreover, raising awareness about better healthcare and a large patient population base is also driving the growth of the hematology analyzer & reagent market in Asia
Report Description: The report covers in-depth analysis of the Global Hematology Analyzer Market. The report assesses the market products by type (Semiautomatic Hematology Analyzers and Automatic Hematology Analyzers), By Product (Instruments and Consumables), By Number of Parameters (Up to 10 Parameters, 10-30 Parameters and Above 30 Parameters). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations
The report includes in-depth company profiles of key players in the Global Hematology Analyzer Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants
Scope:
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market Triangulation
Forecasting
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.